Through her role as CEO of Kalderos, Ms. Franks aims to bring transparency and accountability to the U.S. drug discount ecosystem. Since joining Kalderos in 2023, she led the development and launch of “Truzo”, the industry’s first end-to-end drug pricing and discount management platform, streamlining the compliance process for manufacturers and providers alike. Under her leadership, Kalderos experienced a remarkable 121% year-over-year growth in recurring revenue per employee and uncovered over $1 billion in noncompliance. Her legacy spans decades of leadership in healthcare innovation, with a clear, consistent focus on improving patient access through scalable, ethical technology. She fosters a culture of trust, operational excellence and mission-driven collaboration, ensuring the company delivers real-world value for vulnerable populations.
